Additional predictors of pathological tumor response (TRG 1–3) were the administration of anti-VEGF or anti-EGFR therapies (OR = 9.748, p = 0.001, and OR = 69.830, p < 0.001, respectively) and metastasis size (OR = 0.961, p = 0.049). This evidence concerns the gene EGFR and neoplasm.